Pharma Consulting
Propel Solutions group strives daily to provide superior service and support in a consistent, cost-effective manner. Our ongoing investments in training, research, and technology ensure that our colleagues remain at the top of the industry, and we remain resolutely committed to living up to our reputation for excellence. From small projects to major, long-term remediation engagements, Avventis stands behind each and every solution we deliver — and our wide range of specialties enables us to serve as an end-to-end regulatory compliance partner to our valued clients.
PHARMA VALIDATION CONSULTING SERVIES
- Validation Program Development
- Validation Planning
- Vendor Auditing
- Risk Assessment and Mitigation
- User Requirements Gathering and Documentation
- System Design Documentation (FRS, DS)
- Qualification Protocol (IQ, OQ, PQ) Development
- Qualification Protocol Execution
- Validation Reporting
- Traceability Matrices
- SOP Development and Review
- Validation Project Management
- Validation Gap Analysis and Remediation
DATA MANAGEMENT SERVICES
Data management is the key element in any process. With the help of latest technology, tools, and EDC systems and data integration we successfully provide data management services.
DRUG SAFETY
Drug safety has to monitor by collecting, detection, assessment with pharmaceutical products. Medication errors such as overdose, misuse and abuse of drugs or drug exposure can harm any patient.
REGULATORY AFFAIRS
Propel Regulatory Affairs and Quality Assurance team provides global regulatory and auditing services to the pharmaceutical and biotech industry. We understand the need to maintain 100% compliance with industry regulation and guidelines
Need Creative Consulting Solutions to improve your business Presence ?
Propel Solutions provides customized consulting and support services to the clients across the globe. Our highly experienced team enables us to provide 24/7 support services to the clients. Our consulting and support services are 100% focused and secured.